gamma-aminobutyric acid has been researched along with Metabolic Diseases in 6 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Less than half of patients with schizophrenia obtain full response to antipsychotic drugs and, while clozapine represents the treatment of choice for refractory psychosis, a significant number of individuals remain only partially responsive." | 8.89 | Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters. ( Cohn, T; Hahn, MK; Remington, G; Teo, C, 2013) |
| "Less than half of patients with schizophrenia obtain full response to antipsychotic drugs and, while clozapine represents the treatment of choice for refractory psychosis, a significant number of individuals remain only partially responsive." | 4.89 | Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters. ( Cohn, T; Hahn, MK; Remington, G; Teo, C, 2013) |
| " Although there was no difference in kainate dosing or seizure count between them, the metabolic pattern of injury was different." | 1.43 | Metabolic injury in a variable rat model of post-status epilepticus. ( de Lanerolle, N; Kelly, KM; Pan, JW; Pearce, PS; Rapuano, A; Wu, Y, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fei, F | 1 |
| Lee, KM | 1 |
| McCarry, BE | 1 |
| Bowdish, DM | 1 |
| Pearce, PS | 1 |
| Wu, Y | 1 |
| Rapuano, A | 1 |
| Kelly, KM | 1 |
| de Lanerolle, N | 1 |
| Pan, JW | 2 |
| Hahn, MK | 1 |
| Cohn, T | 1 |
| Teo, C | 1 |
| Remington, G | 1 |
| Williamson, A | 1 |
| Cavus, I | 1 |
| Hetherington, HP | 1 |
| Zaveri, H | 1 |
| Petroff, OA | 1 |
| Spencer, DD | 1 |
| Lin, JJ | 1 |
| Chang, MK | 1 |
| Lockwood, AH | 1 |
3 reviews available for gamma-aminobutyric acid and Metabolic Diseases
| Article | Year |
|---|---|
Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters.
Topics: Anticonvulsants; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Fructose; gamma-Aminobu | 2013 |
Neurometabolism in human epilepsy.
Topics: Animals; Brain Diseases; Brain Mapping; Carbon Isotopes; Dominance, Cerebral; Electrodes, Implanted; | 2008 |
Hemiballism-hemichorea and non-ketotic hyperglycaemia.
Topics: Aged; Basal Ganglia Diseases; Chorea; Dementia, Multi-Infarct; Diabetes Complications; Female; gamma | 1994 |
3 other studies available for gamma-aminobutyric acid and Metabolic Diseases
| Article | Year |
|---|---|
Age-associated metabolic dysregulation in bone marrow-derived macrophages stimulated with lipopolysaccharide.
Topics: Aging; Animals; Arginine; Cells, Cultured; gamma-Aminobutyric Acid; Glycolysis; Inflammation; Lipopo | 2016 |
Metabolic injury in a variable rat model of post-status epilepticus.
Topics: Animals; Aspartic Acid; Cluster Analysis; Creatine; Disease Models, Animal; Electroencephalography; | 2016 |
Metabolic encephalopathies: opportunities and challenges.
Topics: Ammonia; Animals; Brain; Brain Diseases; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Humans; Me | 1987 |